Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Acrocephalosyndactylia × infigratinib × Clear all

Phase

Status

Withdrawn 1 Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Urinary Bladder Neoplasms 2 Tumor With Alterations of the FGF-R 1 Neoplasm Metastasis 1 Melanoma 1 Lung Neoplasms 1 Glioblastoma 1 Cholangiocarcinoma 1 Breast Neoplasms 1 Advanced Gastrointestinal Stromal Tumor (GIST) 1 Acrocephalosyndactylia 1

Interventions

pemigatinib 4 infigratinib 1 erdafitinib 1 derazantinib 1 atezolizumab 1 Rogaratinib 1 INCB 54828-101 1 Drug Combinations 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01928459 2020-12-09

Phase 1b Trial of BGJ398/BYL719 in Solid Tumors

Novartis

Phase 1 Completed

Acrocephalosyndactylia, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡